Hilltop Park Associates’s Biogen BIIB Stock Holding History

Hilltop Park Associates’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$470K	Buy	+1,500	New	+$444K	0.87%	26

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hilltop Park Associates's BIIB Position: Q3 2016 in Review

Hilltop Park Associates opened a new position in Biogen (BIIB) in Q3 2016: 1,500 shares worth $470K. The stake represents 0.87% of the portfolio and ranks #26 among its holdings.

1,012 funds tracked by Wall St. Rank hold BIIB as of Q3 2016.

Hilltop Park Associates held 1,500 shares of Biogen worth $470K as of Q3 2016.
Biogen was a new Hilltop Park Associates position in Q3 2016.
Biogen made up 0.87% of Hilltop Park Associates's portfolio in Q3 2016, its #26 holding.
1,012 funds tracked by Wall St. Rank held Biogen as of Q3 2016.

Based on Hilltop Park Associates's 13F filing for Q3 2016, filed 10 Nov 2016.